Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Breast Cancer Metastatic × patritumab deruxtecan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Neoplasms 2 Esophageal Neoplasms 2 Breast Neoplasms 2 Lung Neoplasms 1 Gastrointestinal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Cancer Metastatic 1

Interventions

pyrotinib 1 patritumab deruxtecan 1 olaparib 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06298084 2024-03-29

ICARUSBREAST02

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1/2 Recruiting

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡